These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
89 related items for PubMed ID: 20564142
1. Clonal origin of multifocal hepatocellular carcinoma. Hodges KB, Cummings OW, Saxena R, Wang M, Zhang S, Lopez-Beltran A, Montironi R, Nour H, Cheng L. Cancer; 2010 Sep 01; 116(17):4078-85. PubMed ID: 20564142 [Abstract] [Full Text] [Related]
2. Evidence for common clonal origin of multifocal lung cancers. Wang X, Wang M, MacLennan GT, Abdul-Karim FW, Eble JN, Jones TD, Olobatuyi F, Eisenberg R, Cummings OW, Zhang S, Lopez-Beltran A, Montironi R, Zheng S, Lin H, Davidson DD, Cheng L. J Natl Cancer Inst; 2009 Apr 15; 101(8):560-70. PubMed ID: 19351924 [Abstract] [Full Text] [Related]
4. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas. Jones TD, Eble JN, Wang M, MacLennan GT, Delahunt B, Brunelli M, Martignoni G, Lopez-Beltran A, Bonsib SM, Ulbright TM, Zhang S, Nigro K, Cheng L. Clin Cancer Res; 2005 Oct 15; 11(20):7226-33. PubMed ID: 16243792 [Abstract] [Full Text] [Related]
5. Molecular evidence supporting field effect in urothelial carcinogenesis. Jones TD, Wang M, Eble JN, MacLennan GT, Lopez-Beltran A, Zhang S, Cocco A, Cheng L. Clin Cancer Res; 2005 Sep 15; 11(18):6512-9. PubMed ID: 16166427 [Abstract] [Full Text] [Related]
6. Molecular evidence for the same clonal origin of multifocal papillary thyroid carcinomas. McCarthy RP, Wang M, Jones TD, Strate RW, Cheng L. Clin Cancer Res; 2006 Apr 15; 12(8):2414-8. PubMed ID: 16638846 [Abstract] [Full Text] [Related]
8. Evidence for polyclonal origin of multifocal clear cell renal cell carcinoma. Cheng L, MacLennan GT, Zhang S, Wang M, Zhou M, Tan PH, Foster S, Lopez-Beltran A, Montironi R. Clin Cancer Res; 2008 Dec 15; 14(24):8087-93. PubMed ID: 19088024 [Abstract] [Full Text] [Related]
9. Molecular genetic evidence supporting the neoplastic nature of the Leydig cell component of ovarian Sertoli-Leydig cell tumors. Emerson RE, Wang M, Roth LM, Zheng W, Abdul-Karim FW, Liu F, Ulbright TM, Eble JN, Cheng L. Int J Gynecol Pathol; 2007 Oct 15; 26(4):368-74. PubMed ID: 17885485 [Abstract] [Full Text] [Related]
13. Clonality analysis of multiple hepatocellular carcinomas by loss of heterozygosity pattern determined by chromosomes 16q and 13q. Lin YW, Lee HS, Chen CH, Huang GT, Lee PH, Sheu JC. J Gastroenterol Hepatol; 2005 Apr 15; 20(4):536-46. PubMed ID: 15836701 [Abstract] [Full Text] [Related]
15. Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma. Nishida N, Fukuda Y, Kokuryu H, Toguchida J, Yandell DW, Ikenega M, Imura H, Ishizaki K. Cancer Res; 1993 Jan 15; 53(2):368-72. PubMed ID: 8093350 [Abstract] [Full Text] [Related]
20. Loss of heterozygosity at chromosome segment Xq25-26.1 in advanced human ovarian carcinomas. Choi C, Cho S, Horikawa I, Berchuck A, Wang N, Cedrone E, Jhung SW, Lee JB, Kerr J, Chenevix-Trench G, Kim S, Barrett JC, Koi M. Genes Chromosomes Cancer; 1997 Nov 15; 20(3):234-42. PubMed ID: 9365830 [Abstract] [Full Text] [Related] Page: [Next] [New Search]